Drug Type Small molecule drug |
Synonyms MK 8507, MK-8507, MK8507 |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H8ClF6N5O3 |
InChIKeyYSFHLBYWQCLYIY-UHFFFAOYSA-N |
CAS Registry1591823-76-5 |
Start Date07 Apr 2025 |
Sponsor / Collaborator |
Start Date09 Mar 2021 |
Sponsor / Collaborator |
Start Date15 Sep 2014 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | US | 09 Mar 2021 | |
HIV Infections | Phase 2 | FR | 09 Mar 2021 | |
HIV Infections | Phase 2 | CH | 09 Mar 2021 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |